Fullerton Fund Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75.8M | Buy |
706,039
+27,188
| +4% | +$2.92M | 3.07% | 10 |
|
|
2025
Q1 | $68.5M | Sell |
678,851
-874,305
| -56% | -$88.2M | 4.4% | 5 |
|
|
2024
Q4 | $139M | Buy |
1,553,156
+533,346
| +52% | +$47.6M | 4.85% | 8 |
|
|
2024
Q3 | $85.5M | Buy |
1,019,810
+812,742
| +393% | +$68.1M | 3.59% | 8 |
|
|
2024
Q2 | $15.9M | Buy |
207,068
+7,159
| +4% | +$551K | 0.72% | 32 |
|
|
2024
Q1 | $13.7M | Buy |
+199,909
| New | +$13.7M | 0.65% | 34 |
|
|
2023
Q3 | – | Sell |
-27,817
| Closed | -$1.5M | – | 59 |
|
|
2023
Q2 | $1.5M | Buy |
+27,817
| New | +$1.5M | 0.11% | 55 |
|